Pembrolizumab versus Ipilimumab in Advanced Melanoma, N Engl J Med, vol.372, pp.2521-2532, 2015. ,
, Cancer Genome Atlas Network, Genomic Classification of Cutaneous Melanoma, Cell, vol.161, pp.1681-1696, 2015.
Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas, Cancer Res, vol.70, pp.3813-3822, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02530789
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma, Nature, vol.480, pp.94-98, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00719536
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma, Nature, vol.480, pp.99-103, 2011. ,
Deciphering the role of oncogenic MITFE318K in senescence delay and melanoma progression, J Natl Cancer Inst, vol.109, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02529960
Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients, J Invest Dermatol, vol.134, pp.141-149, 2014. ,
Genetics of melanoma progression: the rise and fall of cell senescence, Pigment Cell Melanoma Res, vol.29, pp.122-140, 2016. ,
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development, Genes Dev, vol.21, pp.2923-2935, 2007. ,
Beta-catenin signaling controls metastasis in Braf-activated Ptendeficient melanomas, Cancer Cell, vol.20, pp.741-754, 2011. ,